| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/23/2007 | EP1788390A1 Screening method |
| 05/23/2007 | EP1788092A1 Method of inhibiting postischemic reperfusion-induced cell death and cell death inhibitor |
| 05/23/2007 | EP1788083A1 Method of assuming drug sensitivity to cdk4 inhibitor |
| 05/23/2007 | EP1787982A2 11Beta-Hydroxysteroid dehydrogenase type 1 active compounds |
| 05/23/2007 | EP1787657A1 Therapeutic agent for psychoneurotic disease |
| 05/23/2007 | EP1787650A2 A therapeutic composition containing an organosilane quaternary compound and hydrogen peroxide for treating skin disorders |
| 05/23/2007 | EP1787647A1 Remedy for glomerular diseae |
| 05/23/2007 | EP1787646A2 Novel method of treatment |
| 05/23/2007 | EP1787639A2 Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
| 05/23/2007 | EP1787529A2 Composition and methods using an eutomer |
| 05/23/2007 | EP1786466A2 Combination of a chemotherapeutic agent and an antagonist of a gene product for treating tumors |
| 05/23/2007 | EP1786448A1 Use of gsk-3 inhibitors for the treatment of prostate cancer |
| 05/23/2007 | EP1786414A2 Novel statin pharmaceutical compositions and related methods of treatment |
| 05/23/2007 | EP1786409A1 Wound healing |
| 05/23/2007 | EP1786407A1 Use of vitamin ds to treat kidney disease |
| 05/23/2007 | EP1786265A2 Novel compositions and methods of treatment |
| 05/23/2007 | EP1587584B1 Pharmaceutical combination for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
| 05/23/2007 | EP1530494B1 A pharmaceutical preparation containing palladium complex compounds |
| 05/23/2007 | EP1427447A4 Improved therapeutic protocols |
| 05/23/2007 | EP1416929A4 Cancer treatment with gö6976 and its related compounds |
| 05/23/2007 | EP1385548B1 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 05/23/2007 | EP1308512B1 Novel proteins and dnas thereof |
| 05/23/2007 | EP1237845B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 05/23/2007 | EP1218368B1 COMPOSITIONS AND METHODS FOR MODULATING APOPTOSIS IN CELLS OVER-EXPRESSING bcl-2 FAMILY MEMBER PROTEINS |
| 05/23/2007 | EP1181014B1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 05/23/2007 | EP1146788B1 Indomethacin amide derivatives for antiangiogenic and/or antitumorigenic use |
| 05/23/2007 | EP0970203B1 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease in humans |
| 05/23/2007 | EP0948335B1 Methods of treating or preventing cardiac arrhythmia |
| 05/23/2007 | EP0820469B1 Identification, purification and uses of leczymes and carbohydrate ligands |
| 05/23/2007 | CN1968713A Method of regenerating follicles by inhibiting gene capable of inhibiting follicle formation or activating gene capable of inducing follicle formation |
| 05/23/2007 | CN1968695A Compositions comprising immunomodulatory compounds for the treatment and control of myelodysplastic syndromes and using methods |
| 05/23/2007 | CN1968693A Medicine comprising combination of acetylcholine esterase inhibitor and 5-substituted 3-oxadiazolyl-1,6-naphthyridin-2(1H)-one derivative |
| 05/23/2007 | CN1968691A Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis |
| 05/23/2007 | CN1968689A Pharmaceutical compositions containing polyunsaturated fatty acid and at least one of an immunosuppressive agent or an antineoplastic agent |
| 05/23/2007 | CN1966725A Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma |
| 05/23/2007 | CN1966525A Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 05/23/2007 | CN1966080A Neural stem cell injection for treating senile dementia and Parkinson's disease |
| 05/23/2007 | CN1965843A Use of statin and aspirin in preparation of medicine for treating blood high viscosity syndrome |
| 05/23/2007 | CN1965840A Method for preventing weight increase caused by antipsychotic |
| 05/23/2007 | CN1965838A Pharmaceutical composition containing cefpiramide and beta-lactamase inhibitor |
| 05/23/2007 | CN1317301C Modulation of IL-2-and IL-15-mediated T cell responses |
| 05/23/2007 | CN1317030C Treatment of dementia and neurodegenerative diseases with intermediate doses of lhrh antagonists |
| 05/23/2007 | CN1316965C Transparent disappearing external administration carrier |
| 05/22/2007 | US7220867 Dissolving with crystal growth inihibitos; drying |
| 05/22/2007 | US7220832 Dermacentor variabilis GABA-gated chloride channels |
| 05/22/2007 | US7220829 Cytokine binding domain of cytokine receptors |
| 05/22/2007 | US7220780 Naaladase inhibitors for treating retinal disorders and glaucoma |
| 05/22/2007 | US7220778 Methods and devices for epithelial protection during photodynamic therapy |
| 05/22/2007 | US7220774 Protein kinase c inhibitors; antiinflammatory agents; immunosuppresants; antidiabetic agents; immunomodulators |
| 05/22/2007 | US7220749 Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 05/22/2007 | US7220739 Therapeutic application of pro-apoptotic benzodiazepines |
| 05/22/2007 | US7220722 Lipoprotein-regulating medicants |
| 05/22/2007 | US7220575 Melanoma differentiation associated gene-5 and promoter and uses thereof |
| 05/22/2007 | US7220435 Process for the production of glycine enriched NaCI crystals with improved flow |
| 05/22/2007 | US7220407 G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction |
| 05/22/2007 | US7220399 Alpha or beta emitters attached to fragments in radioimmunotherapy |
| 05/22/2007 | US7220272 Composite staple and method for using same |
| 05/22/2007 | CA2321560C The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation |
| 05/22/2007 | CA2241466C Pharmaceutical composition containing angiotensin ii antagonist |
| 05/22/2007 | CA2192093C Agonists and antagonists of the nicotinic acetylcholine receptors of insects to control endoparasites |
| 05/22/2007 | CA2174327C Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women |
| 05/22/2007 | CA2110518C Ctla4 receptor, fusion proteins containing it and uses thereof |
| 05/18/2007 | WO2007056618A1 Compositions and methods for the treatment of addiction and other neuropsychiatric disorders |
| 05/18/2007 | WO2007056324A2 Combination of an angiotensin ii receptor blocker, a calcium channel blocker and another active agent |
| 05/18/2007 | WO2007055743A2 Treatment of obesity and related disorders |
| 05/18/2007 | WO2007055728A1 Treatment of obesity and related disorders |
| 05/18/2007 | WO2007055378A1 Method for treatment or prevention of disease associated with functional disorder of regulatory t cell |
| 05/18/2007 | WO2007055374A1 Therapeutic agent for osteoporosis |
| 05/18/2007 | WO2007055327A1 Jelly composition |
| 05/18/2007 | WO2007055325A2 Preventive/remedy for arteriosclerotic disease and method of evaluating therapeutic procedure |
| 05/18/2007 | WO2007055279A1 Iontophoresis preparation |
| 05/18/2007 | WO2007054975A1 Pharmaceutical compositions for the treatment of cardiovascular and other associated disorders |
| 05/18/2007 | WO2007054731A1 Antiproliferative combination comprising cyc-682 and a cytotoxic agent |
| 05/18/2007 | WO2007054727A1 Combination of roscovitine and a hdca inhibitor to treat prolifeative diseases |
| 05/18/2007 | WO2007054725A2 Combination of a cdk-inhibitor and a hdac-inhibitor |
| 05/18/2007 | WO2007054451A1 Use of combinations of nitric oxide-releasing aspirin and aspirin for the treatment of cardiovascular diseases |
| 05/18/2007 | WO2007053945A1 Oral anti-microbial composition comprising competence-stimulating peptide |
| 05/18/2007 | WO2007003411A3 Kinin antagonists for treating bladder dysfunction |
| 05/18/2007 | WO2006015775A3 Egfr kinase inhibitor combinations for treating respiratory and gastrointestinal disorders |
| 05/18/2007 | WO2005011603A3 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
| 05/18/2007 | WO2003076594A3 Genomic screen for epigenetically silenced tumor suppressor genes |
| 05/18/2007 | CA2629199A1 Compositions and methods for the treatment of addiction and other neuropsychiatric disorders |
| 05/18/2007 | CA2628848A1 Compositions and methods for treating thrombocytopenia |
| 05/18/2007 | CA2628305A1 Jelly composition |
| 05/18/2007 | CA2628051A1 Treatment of obesity and related disorders |
| 05/18/2007 | CA2626682A1 Combination of an angiotensin ii receptor blocker, a calcium channel blocker and another active agent |
| 05/17/2007 | US20070112061 Heat- or singlet oxygen-generating agents and cancer treatment compositions comprising organic peroxide or chemiluminescent compound |
| 05/17/2007 | US20070112013 Method of modulating ion channel functional activity |
| 05/17/2007 | US20070111973 Treatment of tumours |
| 05/17/2007 | US20070111942 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/17/2007 | US20070111934 Procaspase 1 activation inhibitor |
| 05/17/2007 | US20070110826 Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision |
| 05/17/2007 | US20070110797 Methods and Compositions For Topical Wound Treatment |
| 05/17/2007 | US20070110745 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 05/17/2007 | US20070110715 Treatment of alzheimer's disease |
| 05/17/2007 | US20070110698 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 05/16/2007 | EP1785486A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/16/2007 | EP1785433A1 Viral particle-like construct and method of forming the same under physiological conditions |
| 05/16/2007 | EP1785424A2 Fused 1,2,4-triazoles and pharmaceutical uses thereof |
| 05/16/2007 | EP1785421A1 Tropan compound |